Why the study?
Do depression treatments improve depression and glycemic control in patients with comorbid depression and diabetes mellitus?
Do depression treatments improve depression and glycemic control in patients with comorbid depression and diabetes mellitus?
Treatments for depression in patients with diabetes are effective for improving depressive symptoms, but their impact on glycemic control varies and depends on baseline characteristics.
Answers are grounded in this paper and cite their sources.
Depression treatments warrant use in comorbid diabetes for mood benefits; extends evidence that glycemic effects vary by baseline depression and HbA1c.
All treatments are effective for comorbid depression in type 1 diabetes and type 2 diabetes. Over the last decade, new interventions with large effect sizes have been introduced, such as group-based therapy, online treatment, and exercise. Although all interventions were effective for depression, not all treatments were effective for glycemic control. Effective interventions in comorbid depressive disorder may not be as effective in comorbid subthreshold depression. Baseline depression and HbA₁ c scores modify the treatment effect. Based on the findings, we provide guidance for treatment depending on patient profile and desired outcome, and discuss possible avenues for further research.
No takes yet. Share an insight, caveat, or question.
Feltz‐Cornelis et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: